200,000+ products from a single source!
sales@angenechem.com
30461-91-7 | Cholest-5-en-3-ol, 19-(iodo-125I)-, (3β)- (9CI)
CAS No: 30461-91-7 Catalog No: AG00306Q MDL No:
Product Description
Catalog Number:
AG00306Q
Chemical Name:
Cholest-5-en-3-ol, 19-(iodo-125I)-, (3β)- (9CI)
CAS Number:
30461-91-7
IUPAC Name:
(3S,8S,9S,10S,13R,14S,17R)-10-((125I)iodanylmethyl)-13-methyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
InChI:
InChI=1S/C27H45IO/c1-18(2)6-5-7-19(3)23-10-11-24-22-9-8-20-16-21(29)12-15-27(20,17-28)25(22)13-14-26(23,24)4/h8,18-19,21-25,29H,5-7,9-17H2,1-4H3/t19-,21+,22+,23-,24+,25+,26-,27-/m1/s1/i28-2
InChI Key:
FIOAEFCJGZJUPW-HEDRMPLKSA-N
UNII:
568E3L437Z
Properties
Complexity:
612
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
8
Defined Bond Stereocenter Count:
0
Exact Mass:
510.252g/mol
Formal Charge:
0
Heavy Atom Count:
29
Hydrogen Bond Acceptor Count:
1
Hydrogen Bond Donor Count:
1
Isotope Atom Count:
1
Molecular Weight:
510.561g/mol
Monoisotopic Mass:
510.252g/mol
Rotatable Bond Count:
6
Topological Polar Surface Area:
20.2A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
9.3
Literature
| Title | Journal |
|---|---|
| A concomitant false-negative ¹⁸F-FDG PET imaging in an adrenocortical carcinoma and a high uptake in a corresponding liver metastasis. | The Journal of clinical endocrinology and metabolism 20120401 |
| [ACTH-independent macronodular adrenal hyperplasia and subclinical Cushing's syndrome]. | Medicina clinica 20120204 |
| Quantitative imaging characterization of hypersecreting or nonhypersecreting adrenal adenomas: comparison between iodine-131 norcholesterol uptake and magnetic resonance signal intensity ratios. | Nuclear medicine communications 20110601 |
| [Adrenal incidentaloma and nuclear medicine examination]. | Journal de radiologie 20090301 |
| Quantitative evaluation of norcholesterol scintigraphy, CT attenuation value, and chemical-shift MR imaging for characterizing adrenal adenomas. | Annals of nuclear medicine 20080701 |
| Prevention of tumor recurrence and distant metastasis formation in a breast cancer mouse model by biodegradable implant of 131I-norcholesterol. | Journal of controlled release : official journal of the Controlled Release Society 20071106 |
| High risk of malignancy in patients with incidentally discovered adrenal masses: accuracy of adrenal imaging and image-guided fine-needle aspiration cytology. | Tumori 20070101 |
| Crosslinked chitosan implants as potential degradable devices for brachytherapy: in vitro and in vivo analysis. | Journal of controlled release : official journal of the Controlled Release Society 20060410 |
| A case of ganglioneuroma in which 131I-6beta-iodomethyl-19-norcholest-5(10)-en-3beta-ol scintigraphy showed high uptake in the adrenal gland leading to a misdiagnosis. | Annals of nuclear medicine 20060101 |
| Tomographic evaluation of [131I] 6beta-iodomethyl-norcholesterol standardised uptake trend in clinically silent monolateral and bilateral adrenocortical incidentalomas. | The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of... 20050901 |
| Collision/composite tumors of the adrenal gland: a pitfall of scintigraphy imaging and hormone assays in the detection of adrenal metastasis. | The Journal of clinical endocrinology and metabolism 20050801 |
| Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 7-2005. A 59-year-old woman with an incidentally discovered adrenal nodule. | The New England journal of medicine 20050310 |
| Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques. | The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of... 20040901 |
| [Contribution of the scintigraphy with iodocholesterol (I-COL) to the diagnosis and characterization of silent adrenal masses]. | Revista espanola de medicina nuclear 20040101 |
| [Adrenal cortex scintigraphy with and without dexamethasone suppression in the study of primary aldosteronism]. | Revista espanola de medicina nuclear 20040101 |
| SPECT semiquantitative analysis of adrenocortical (131)I-6 beta iodomethyl-norcholesterol uptake to discriminate subclinical and preclinical functioning adrenal incidentaloma. | Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20030701 |
| Scintigraphic features of a pure estrogen-secreting adrenocortical adenoma in a patient with gynecomastia. | Clinical nuclear medicine 20021001 |
| Diagnostic accuracy of radionuclide imaging using 131I nor-cholesterol or meta-iodobenzylguanidine in patients with hypersecreting or non-hypersecreting adrenal tumours. | Nuclear medicine communications 20021001 |
| The diagnostic role of radionuclide imaging in evaluation of patients with nonhypersecreting adrenal masses. | Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20010601 |
| Role of molecular imaging in management of nonhypersecreting adrenal masses. | Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20010601 |
Related Products
© 2019 Angene International Limited. All rights Reserved.